XML 40 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Aug. 31, 2015
Aug. 31, 2014
Cash provided (used) by operating activities:    
Net income $ 44,862 $ 35,237
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 21,227 18,493
Amortization of financing costs 580 858
Provision for doubtful receivables 128 16
Non-cash share-based compensation 3,938 3,212
Intangible asset impairment charges 3,000 9,000
Loss on the sale of property and equipment   40
Deferred income taxes and tax credits (5,679) 294
Changes in operating capital, net of effects of acquisition of business:    
Receivables (4,776) (3,771)
Inventories (55,382) (56,468)
Prepaid expenses and other current assets (1,715) 701
Other assets and liabilities, net (1,691) 1,222
Accounts payable 44,538 32,648
Accrued expenses and other current liabilities 1,397 (20,563)
Accrued income taxes 1,191 (2,924)
Net cash provided by operating activities 51,618 17,995
Cash provided (used) by investing activities:    
Capital and intangible asset expenditures (5,946) (3,688)
Proceeds from the sale of property and equipment 7  
Payments to acquire businesses (42,750) (195,943)
Net cash used by investing activities (48,689) (199,631)
Cash provided (used) by financing activities:    
Proceeds from line of credit 289,900 640,900
Repayment of line of credit (241,900) (152,000)
Repayment of long-term debt (1,900) (76,900)
Payment of financing costs (19) (2,321)
Proceeds from share issuances under share-based compensation plans, including tax benefits 7,507 4,528
Payment of tax obligations resulting from cashless share award exercises   (4,569)
Payments for repurchases of common stock (50,000) (273,599)
Share-based compensation tax benefit 593 296
Net cash provided (used) by financing activities 4,181 136,335
Net increase (decrease) in cash and cash equivalents 7,110 (45,301)
Cash and cash equivalents, beginning balance 12,295 70,027
Cash and cash equivalents, ending balance $ 19,405 $ 24,726